Regulatory T cells as therapeutic targets and mediators.
Foxp3
Treg
cancer
immune therapy
regulatory T cells
tumor immunity
Journal
International reviews of immunology
ISSN: 1563-5244
Titre abrégé: Int Rev Immunol
Pays: England
ID NLM: 8712260
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
4
6
2019
medline:
20
2
2020
entrez:
4
6
2019
Statut:
ppublish
Résumé
With the advent of the concept of dominant tolerance and the subsequent discovery of CD4
Identifiants
pubmed: 31154878
doi: 10.1080/08830185.2019.1621310
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM